Vision Loss Secondary to Autologous Adipose Stem Cell Injections: A Rising Problem.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  JAMA ophthalmology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jamaophthalmol.2017.5453PMID 29192301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD.

  2017cited by this paper
• Complication of Autologous Stem Cell Transplantation in Retinitis Pigmentosa.

  2016cited by this paper
• Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.

  2015cited by this paper
• US stem cell clinics, patient safety, and the FDA.

  2015cited by this paper

• Cell therapy for retinal disease

  2024cites this paper
• Update on "Cell Therapy" Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S.

  2024cites this paper
• Therapeutic Extracellular Vesicles from Tonsil-Derived Mesenchymal Stem Cells for the Treatment of Retinal Degenerative Disease

  2023cites this paper
• Administration of Melatonin in Diabetic Retinopathy Is Effective and Improves the Efficacy of Mesenchymal Stem Cell Treatment

  2022cites this paper
• Stem Cell and Gene Therapy for Inherited Retinal Diseases

  2022cites this paper
• Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined with Anti-VEGF Nanocarriers, in a Pharmaceutically Induced Animal Model of Retinal Vein Occlusion

  2022cites this paper
• A Long-Term Safety and Efficacy Report on Intravitreal Delivery of Adipose Stem Cells and Secretome on Visual Deficits After Traumatic Brain Injury

  2022cites this paper
• New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics

  2022cites this paper
• Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer “cell therapy” clinics

  2021cites this paper
• Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment

  2021cites this paper
• Stem Cell Therapy for Retinal Degeneration: The Evidence to Date

  2021cites this paper
• A Modified Surgical Technique for Submacular Injection.

  2021cites this paper
• BTT_A_290331 299..306

  2021cites this paper
• Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium

  2020cites this paper
• Chronic retinal detachment and neovascular glaucoma after intravitreal stem cell injection for Usher Syndrome

  2020cites this paper
• Retinal stem cell transplantation: Balancing safety and potential.

  2020cites this paper
• Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.

  2019cites this paper
• Clinicopathologic Correlations of Retinal Membranes Associated With Intravitreal 'Stem Cell' Injections.

  2019cites this paper
• Cash-Based Stem-Cell Clinics: The Modern Day Snake Oil Salesman? A Report of Two Cases of Patients Harmed by Intra-articular Stem Cell Injections.

  2019cites this paper
• Direct-to-consumer marketing of stem cell interventions by Canadian businesses.

  2018cites this paper
• Mapping and driving the stem cell ecosystem.

  2018cites this paper
• Too Much Carrot and Not Enough Stick in New Stem Cell Oversight Trends.

  2018cites this paper